Want to see CTMX full AI Analyst Report?
CytomX Therapeutics (CTMX) Q2 2026 Earnings Report
CTMX Q2 2026 EPS Results
- Actual EPS
- -$0.09
- Consensus EPS
- -$0.08
- Beat/Miss
- Missed by -$0.01
- One Year Ago EPS
- $0.00
CTMX Q2 2026 Revenue Results
- Actual Revenue
- $1.42M
- Expected Revenue
- $12.39M
- Beat/Miss
- Missed by -$10.97M
- YoY Revenue Growth
- -92.40%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/06/2026
- Time
- After Close
- Conference Call
- Thursday, August 6, 2026
CTMX Upcoming Earnings
CytomX Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
CTMX Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
CTMX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | -0.07- | -0.09 | ― | ― |
| Aug 06, 2026 | 2026 (Q2) | -0.08-0.09 | 0 | ― | |
| May 07, 2026 | 2026 (Q1) | -0.12-0.10 | 0.27 | -137.04% (-0.37) | |
| Mar 16, 2026 | 2025 (Q4) | -0.09-0.17 | 0.22 | -178.64% (-0.39) | |
| Nov 06, 2025 | 2025 (Q3) | -0.05-0.09 | 0.07 | -228.57% (-0.16) | |
| Aug 07, 2025 | 2025 (Q2) | -0.060.00 | -0.08 | 100.00% (+0.08) | |
| May 12, 2025 | 2025 (Q1) | 0.130.27 | 0.17 | 58.82% (+0.10) | |
| Mar 06, 2025 | 2024 (Q4) | -0.200.22 | 0.02 | 1000.00% (+0.20) | |
| Nov 07, 2024 | 2024 (Q3) | -0.170.07 | 0.04 | 75.00% (+0.03) | |
| Aug 08, 2024 | 2024 (Q2) | -0.10-0.08 | -0.02 | -300.00% (-0.06) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
